Procalcitonin as a diagnostic marker for sepsis: A systematic review and meta-analysis

The Lancet Infectious Diseases

Volumn 13, Issue 5, 2013, Pages 426-435

  Wacker, Christina ^a   Prkno, Anna ^a   Brunkhorst, Frank M ^a   Schlattmann, Peter ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROCALCITONIN;

AREA UNDER THE CURVE; ARTICLE; COCHRANE LIBRARY; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; EMBASE; HOSPITAL ADMISSION; HUMAN; MEDICAL HISTORY; MEDLINE; META ANALYSIS; MICROBIOLOGICAL EXAMINATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; SYSTEMATIC REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGE FACTORS; BIOLOGICAL MARKERS; CALCITONIN; CRITICAL ILLNESS; DATABASES, FACTUAL; HUMANS; PREVALENCE; PROTEIN PRECURSORS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84876708502     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(12)70323-7     Document Type: Article

References (82)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
2. Martin GS, Mannino DM, Eaton S, Moss M The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554.
3. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest 2009, 136(suppl):e28.
4. Bates DW, Cook EF, Goldman L, Lee TH Predicting bacteremia in hospitalized patients. A prospectively validated model. Ann Intern Med 1990, 113:495-500.
5. Bates DW, Sands K, Miller E, et al. Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. J Infect Dis 1997, 176:1538-1551.
6. Garnacho-Montero J, Ortiz-Leyba C, Herrera-Melero I, et al. Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study. J Antimicrob Chemother 2008, 61:436-441.
7. Pittet D, Rangel-Frausto S, Li N, et al. Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: incidence, morbidities and outcomes in surgical ICU patients. Intensive Care Med 1995, 21:302-309.
8. Moyer MW New biomarkers sought for improving sepsis management and care. Nat Med 2012, 18:999.
9. Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994, 79:1605-1608.
10. Tang BM, Eslick GD, Craig JC, McLean AS Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007, 7:210-217.
11. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006, 34:1996-2003.
12. Reinhart K, Brunkhorst FM, Bone HG, et al. Prevention, diagnosis, treatment, and follow-up care of sepsis. First revision of the S2k Guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association for Intensive and Emergency Care Medicine (DIVI). Anaesthesist 2010, 59:347-370. (in German).
13. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003, 3:25.
14. Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 2006, 6:9.
15. Whiting P, Harbord R, Kleijnen J No role for quality scores in systematic reviews of diagnostic accuracy studies. BMC Med Res Methodol 2005, 5:19.
16. Chu H, Cole SR Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach. J Clin Epidemiol 2006, 59:1331-1332.
17. Van Houwelingen HC, Zwinderman KH, Stijnen T A bivariate approach to meta-analysis. Stat Med 1993, 12:2273-2284.
18. van Houwelingen HC, Arends LR, Stijnen T Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 2002, 21:589-624.
19. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 2005, 58:982-990.
20. Riley RD, Abrams KR, Sutton AJ, Lambert PC, Thompson JR Bivariate random-effects meta-analysis and the estimation of between-study correlation. BMC Med Res Methodol 2007, 7:3.
21. Deeks JJ, Macaskill P, Irwig L The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 2005, 58:882-893.
22. Dwamena BA Midas: a program for meta-analytical integration of diagnostic accuracy studies in stata. 2007. University of Michigan (accessed Jan 15, 2013). http://sitemaker.umich.edu/metadiagnosis/midas_home.
23. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004, 39:206-217.
24. Ahmadinejad Z, Dadsetan B, Jalili M, Soudbakhsh A, Rasolinejad M Evaluation of serum procalcitonin in patients with systemic inflammatory response syndrome with and without infection. Acta Med Iran 2009, 47:383-388.
25. Al-Nawas B, Krammer I, Shah PM Procalcitonin in diagnosis of severe infections. Eur J Med Res 1996, 1:331-333.
26. Arkader R, Troster EJ, Lopes MR, et al. Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome. Arch Dis Child 2006, 91:117-120.
27. Bell K, Wattie M, Byth K, et al. Procalcitonin: a marker of bacteraemia in SIRS. Anaesth Intensive Care 2003, 31:629-636.
28. Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 2004, 8:R234-R242.
29. Clec'h C, Fosse JP, Karoubi P, et al. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 2006, 34:102-107.
30. Dorizzi RM, Polati E, Sette P, Ferrari A, Rizzotti P, Luzzani A Procalcitonin in the diagnosis of inflammation in intensive care units. Clin Biochem 2006, 39:1138-1143.
31. Du B, Pan J, Chen D, Li Y Serum procalcitonin and interleukin-6 levels may help to differentiate systemic inflammatory response of infectious and non-infectious origin. Chin Med J (Engl) 2003, 116:538-542.
32. Gaini S, Koldkjaer OG, Pedersen C, Pedersen SS Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care 2006, 10:R53.
33. Gibot S, Kolopp-Sarda MN, Bene MC, et al. Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 2004, 141:9-15.
34. Groselj-Grenc M, Ihan A, Pavcnik-Arnol M, Kopitar AN, Gmeiner-Stopar T, Derganc M Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children. Intensive Care Med 2009, 35:1950-1958.
35. Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001, 164:396-402.
36. Hsu KH, Chan MC, Wang JM, Lin LY, Wu CL Comparison of Fcgamma receptor expression on neutrophils with procalcitonin for the diagnosis of sepsis in critically ill patients. Respirology 2011, 16:152-160.
37. Ivancevic N, Radenkovic D, Bumbasirevic V, et al. Procalcitonin in preoperative diagnosis of abdominal sepsis. Langenbecks Arch Surg 2008, 393:397-403.
38. Jimeno A, Garcia-Velasco A, del Val O, et al. Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia. Cancer 2004, 100:2462-2469.
39. Kofoed K, Andersen O, Kronborg G, et al. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 2007, 11:R38.
40. Latour-Perez J, Alcala-Lopez A, Garcia-Garcia MA, et al. Diagnostic accuracy of sTREM-1 to identify infection in critically ill patients with systemic inflammatory response syndrome. Clin Biochem 2010, 43:720-724.
41. Meynaar IA, Droog W, Batstra M, Vreede R, Herbrink P In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il-6, or LBP. Crit Care Res Pract 2011, 2011:594645.
42. Naeini AE, Montazerolghaem S Procalcitonin marker for sepsis diagnosis. Evaluating a rapid immuno-chromatografic test. Saudi Med J 2006, 27:422-424.
43. Oshita H, Sakurai J, Kamitsuna M Semi-quantitative procalcitonin test for the diagnosis of bacterial infection: clinical use and experience in Japan. J Microbiol Immunol Infect 2010, 43:222-227.
44. Pavcnik-Arnol M, Hojker S, Derganc M Lipopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children. Intensive Care Med 2007, 33:1025-1032.
45. Ruiz-Alvarez MJ, Garcia-Valdecasas S, De Pablo R, et al. Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis. J Intensive Care Med 2009, 24:63-71.
46. Sakr Y, Burgett U, Nacul FE, Reinhart K, Brunkhorst F Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis?. Crit Care Med 2008, 36:2014-2022.
47. Selberg O, Hecker H, Martin M, Klos A, Bautsch W, Kohl J Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 2000, 28:2793-2798.
48. Simon L, Saint-Louis P, Amre DK, Lacroix J, Gauvin F Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome. Pediatr Crit Care Med 2008, 9:407-413.
49. Suprin E, Camus C, Gacouin A, et al. Procalcitonin: a valuable indicator of infection in a medical ICU?. Intensive Care Med 2000, 26:1232-1238.
50. Tsalik EL, Jaggers LB, Glickman SW, et al. Discriminative value of inflammatory biomarkers for suspected sepsis. J Emerg Med 2012, 43:97-106.
51. Tsangaris I, Plachouras D, Kavatha D, et al. Diagnostic and prognostic value of procalcitonin among febrile critically ill patients with prolonged ICU stay. BMC Infect Dis 2009, 9:213.
52. Tugrul S, Esen F, Celebi S, et al. Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response. Anaesth Intensive Care 2002, 30:747-754.
53. Wanner GA, Keel M, Steckholzer U, Beier W, Stocker R, Ertel W Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 2000, 28:950-957.
54. Aouifi A, Piriou V, Bastien O, et al. Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med 2000, 28:3171-3176.
55. Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 2000, 26(suppl 2):S148-S152.
56. Baumgarten R, Pequeriaux NCV, Van Puyenbroek MJE, Speelberg B Diagnosis of sepsis by procalcitonin. Nederlands Tijdschrift voor de Klinische Chemie 2002, 27:32-35. (in Dutch).
57. Chan YL, Tseng CP, Tsay PK, Chang SS, Chiu TF, Chen JC Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit Care 2004, 8:R12-R20.
58. Cheval C, Timsit JF, Garrouste-Orgeas M, et al. Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients. Intensive Care Med 2000, 26(suppl 2):S153-S158.
59. Clec'h C, Ferriere F, Karoubi P, et al. Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 2004, 32:1166-1169.
60. Geppert A, Steiner A, Delle-Karth G, Heinz G, Huber K Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock. Intensive Care Med 2003, 29:1384-1389.
61. Giamarellos-Bourboulis EJ, Mega A, Grecka P, et al. Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?. Intensive Care Med 2002, 28:1351-1356.
62. Hensler T, Sauerland S, Lefering R, et al. The clinical value of procalcitonin and neopterin in predicting sepsis and organ failure after major trauma. Shock 2003, 20:420-446.
63. Mokart D, Merlin M, Sannini A, et al. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth 2005, 94:767-773.
64. Rothenburger M, Markewitz A, Lenz T, et al. Detection of acute phase response and infection. The role of procalcitonin and C-reactive protein. Clin Chem Lab Med 1999, 37:275-279.
65. Ruokonen E, Ilkka L, Niskanen M, Takala J Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol Scand 2002, 46:398-404.
66. Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999, 27:498-504.
67. Bossink AW, Groeneveld AB, Thijs LG Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha1-antitrypsin, and lactoferrin compared with clinical variables. Clin Infect Dis 1999, 29:398-407.
68. Hausfater P, Garric S, Ayed SB, Rosenheim M, Bernard M, Riou B Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study. Clin Infect Dis 2002, 34:895-901.
69. Meisner M, Rauschmayer C, Schmidt J, et al. Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive Care Med 2002, 28:1094-1102.
70. Balc IC, Sungurtekin H, Gurses E, Sungurtekin U, Kaptanoglu B Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care 2003, 7:85-90.
71. Benoist JF, Mimoz O, Assicot M, Edouard A Serum procalcitonin, but not C-reactive protein, identifies sepsis in trauma patients. Clin Chem 1998, 44:1778-1779.
72. de Talancé N, Claudel C, Burlet C La procalcitonine (PCT) est-elle le marqueur spécifique du choc septique?. Immuno-analyse & Biologie Spécialisée 2003, 18:120-122.
73. Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003, 31:1737-1741.
74. Oberhoffer M, Karzai W, Meier-Hellmann A, Bogel D, Fassbinder J, Reinhart K Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-alpha and interleukin-6 in patients with sepsis. Crit Care Med 1999, 27:1814-1818.
75. Muller B, Becker KL, Schachinger H, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000, 28:977-983.
76. Dorge H, Schondube FA, Dorge P, Seipelt R, Voss M, Messmer BJ Procalcitonin is a valuable prognostic marker in cardiac surgery but not specific for infection. Thorac Cardiovasc Surg 2003, 51:322-326.
77. Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM, Kleijnen J Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med 2004, 140:189-202.
78. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Fam Pract 2004, 21:4-10.
79. Schuetz P, Chiappa V, Briel M, Greenwald JL Procalcitonin algorithms for antibiotic therapy decisions. a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011, 171:1322-1331.
80. Schuetz P, Briel M, Christ-Crain M, et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis 2012, 55:651-662.
81. Fischer JE, Bachmann LM, Jaeschke R A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med 2003, 29:1043-1051.
82. Backes Y, van der Sluijs KF, Mackie DP, et al. Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review. Intensive Care Med 2012, 38:1418-1428.